After the Supreme Court issued its ruling on Dobbs v. Jackson Women’s Health Organization last year, the case that overturned Roe v. Wade, companies were suddenly thrust into the spotlight on abortion and pressured to make difficult choices regarding reproductive health care and their workforces. Now, investors on both sides of the issue are using the power of the proxy to probe companies on abortion and reproductive health, more than doubling the number of proposals filed year over year on political spending, risk oversight, data tracking and other issues linked to the topic.
…Last year, Rhia led a group of investors in filing 11 proposals that inquired about a potential misalignment between the companies’ stated values and political spending, along with four proposals on companies’ preparedness for workplace repercussions related to the overturning of Roe v. Wade. Such proposals received between 30% and 47% support, according to Rhia.
Public company intelligence provider MyLogIQ only tracked three proposals that directly mentioned reproductive health care that went to a vote at Russell 3000 companies in 2022, according to data provided to Agenda. None of the proposals passed, and the average support was 24.4%.
Compensation committees at S&P 500 companies are increasingly tying annual bonuses to measures beyond financial…
The pay gap between CEOs and their employees has widened over the past half decade,…
Chip maker Broadcom gave Hock Tan, its chief executive, a $161 million stock award, instantly…
Elon's Musk's $56 billion pay package's upheaval, a hedge fund sanctioned for failing to preserve…
Disclosures about directors' skills and expertise are increasingly coming under the microscope as investors ramp…
On Jan. 1, several of the nation's biggest companies — including Morgan Stanley, Kraft Heinz,…